相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A systematic approach to therapeutic target selection in oesophago-gastric cancer
Anna L. Paterson et al.
GUT (2013)
UTILIZING INTEGRATIVE GENOMIC ANALYSIS AND PROTEOMICS TO DECIPHER THE BIOLOGY AND THERAPEUTIC POTENTIAL OF TRIM44 IN OESOPHAGEAL ADENOCARCINOMA AND BREAST CANCER
J. C. Ong et al.
GUT (2013)
Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal Adenocarcinoma
Chin-Ann J. Ong et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes
Harry Hemingway et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
Richard D. Riley et al.
PLOS MEDICINE (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma
Kingo Kashimoto et al.
CANCER SCIENCE (2012)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman et al.
PLOS MEDICINE (2012)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
RNA interference in the clinic: challenges and future directions
Chad V. Pecot et al.
NATURE REVIEWS CANCER (2011)
Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?
Heiko Pohl et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
A 4-Gene Signature Predicts Survival of Patients With Resected Adenocarcinoma of the Esophagus, Junction, and Gastric Cardia
Christopher J. Peters et al.
GASTROENTEROLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome
Soo Mi Kim et al.
PLOS ONE (2010)
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
Brian J. Reid et al.
NATURE REVIEWS CANCER (2010)
TRIM family proteins and their emerging roles in innate immunity
Keiko Ozato et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth
Romain Parent et al.
CANCER RESEARCH (2007)
Gene expression profiling of esophageal cancer: Comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma
Danielle M. Greenawalt et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Biomarkers in cancer staging, prognosis and treatment selection
JA Ludwig et al.
NATURE REVIEWS CANCER (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus
M Sarbia et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
